Patents by Inventor Roy Alston

Roy Alston has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11834491
    Abstract: Aspects of the invention are directed to arginine-free polypeptide-containing compositions and methods for treating disorders associated with inflammation or the autoimmune response. In particular, the polypeptide is etanercept.
    Type: Grant
    Filed: March 30, 2021
    Date of Patent: December 5, 2023
    Assignee: Biogen MA Inc.
    Inventors: Kevin Maloney, Ke Gong, Roy Alston
  • Publication number: 20210309719
    Abstract: Aspects of the invention are directed to arginine-free polypeptide-containing compositions and methods for treating disorders associated with inflammation or the autoimmune response. In particular, the polypeptide is etanercept.
    Type: Application
    Filed: March 30, 2021
    Publication date: October 7, 2021
    Applicant: Biogen MA Inc.
    Inventors: Kevin Maloney, Ke Gong, Roy Alston
  • Patent number: 10995130
    Abstract: Aspects of the invention are directed to arginine-free polypeptide-containing compositions and methods for treating disorders associated with inflammation or the autoimmune response. In particular, the polypeptide is etanercept.
    Type: Grant
    Filed: June 29, 2012
    Date of Patent: May 4, 2021
    Assignee: Biogen MA Inc.
    Inventors: Kevin Maloney, Ke Gong, Roy Alston
  • Publication number: 20170355729
    Abstract: Disclosed herein are methods of purifying monoclonal antibodies and related compositions.
    Type: Application
    Filed: December 2, 2015
    Publication date: December 14, 2017
    Applicant: Biogen MA Inc.
    Inventors: Matthew Westoby, Alex Brinkmann, Ryan Haverstock, Roy Alston
  • Publication number: 20140255400
    Abstract: Aspects of the invention are directed to arginine-free polypeptide-containing compositions and methods for treating disorders associated with inflammation or the autoimmune response. In particular, the polypeptide is etanercept.
    Type: Application
    Filed: June 29, 2012
    Publication date: September 11, 2014
    Applicant: Biogen Idec MA Inc.
    Inventors: Kevin Maloney, Ke Gong, Roy Alston